PT2869854T - Composição contendo ectoína ou hidroxiectoína como substância ativa, para promover a regeneração de tecido corporal lesionado - Google Patents
Composição contendo ectoína ou hidroxiectoína como substância ativa, para promover a regeneração de tecido corporal lesionadoInfo
- Publication number
- PT2869854T PT2869854T PT13737554T PT13737554T PT2869854T PT 2869854 T PT2869854 T PT 2869854T PT 13737554 T PT13737554 T PT 13737554T PT 13737554 T PT13737554 T PT 13737554T PT 2869854 T PT2869854 T PT 2869854T
- Authority
- PT
- Portugal
- Prior art keywords
- hydroxyecotine
- ecotine
- regeneration
- promoting
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012013482.7A DE102012013482A1 (de) | 2012-07-09 | 2012-07-09 | Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2869854T true PT2869854T (pt) | 2019-07-15 |
Family
ID=48794047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT13737554T PT2869854T (pt) | 2012-07-09 | 2013-06-19 | Composição contendo ectoína ou hidroxiectoína como substância ativa, para promover a regeneração de tecido corporal lesionado |
Country Status (11)
Country | Link |
---|---|
US (3) | US20150297592A1 (pt) |
EP (3) | EP2869854B1 (pt) |
CN (2) | CN107252427B (pt) |
DE (1) | DE102012013482A1 (pt) |
DK (1) | DK2869854T3 (pt) |
ES (2) | ES2734252T3 (pt) |
HU (1) | HUE044118T2 (pt) |
PL (1) | PL2869854T3 (pt) |
PT (1) | PT2869854T (pt) |
TR (1) | TR201909626T4 (pt) |
WO (1) | WO2014009118A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3120841A1 (de) * | 2015-07-23 | 2017-01-25 | Christophe Sivanzire | Pharmazeutisches präparat |
DE102015121050A1 (de) * | 2015-12-03 | 2017-06-08 | Bitop Ag | Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben |
DE102016111882A1 (de) * | 2016-06-29 | 2018-01-04 | Bitop Ag | Zusammensetzung zur Bekämpfung von gastroösophagealen Refluxerkrankungen |
TWI629265B (zh) * | 2017-04-13 | 2018-07-11 | 元智大學 | Reactive raw humectant and its preparation |
US10543158B2 (en) | 2017-04-17 | 2020-01-28 | W Skincare, LLC | Autophagy activating complex, compositions and methods |
CN107375996B (zh) * | 2017-07-31 | 2018-09-21 | 长沙海润生物技术有限公司 | 一种生物功能性敷料及其制备方法 |
CN107496661A (zh) * | 2017-09-11 | 2017-12-22 | 南京华开生物科技有限公司 | 硅酮疤痕凝胶及其制备方法 |
JP6315533B1 (ja) * | 2018-02-01 | 2018-04-25 | 株式会社ノエビア | 皮膚外用剤 |
CN110732802A (zh) * | 2018-10-22 | 2020-01-31 | 嘉兴学院 | 细间距焊盘键合用缓蚀助焊剂及其制备方法 |
CN109731123A (zh) * | 2019-02-25 | 2019-05-10 | 湖南博隽生物医药有限公司 | 一种医学护理用抗感染材料及其制备方法 |
TWI723482B (zh) * | 2019-07-31 | 2021-04-01 | 嘉會生技股份有限公司 | 促進富含血小板血漿釋放生長因子之方法 |
CN110575403A (zh) * | 2019-10-25 | 2019-12-17 | 深圳市阳光优品科技有限公司 | 一种可减少防晒乳中的化学防晒剂添加量的制备方法 |
CN110859775A (zh) * | 2019-12-03 | 2020-03-06 | 中国科学院青岛生物能源与过程研究所 | 甘油葡萄糖苷在透皮吸收组合物中的应用 |
CN111172127A (zh) * | 2020-01-17 | 2020-05-19 | 浙江工业大学 | 一种蔗糖磷酸化酶在制备甘油葡萄糖苷中的应用 |
CN111773222A (zh) * | 2020-08-10 | 2020-10-16 | 华熙生物科技股份有限公司 | 四氢嘧啶和/或羟基四氢嘧啶在制备治疗烧烫伤药物中的应用 |
CN112107720A (zh) * | 2020-09-18 | 2020-12-22 | 华熙生物科技股份有限公司 | 透气性好的医用压敏胶及依克多因在提高医用压敏胶透气性中的应用 |
CN115192602B (zh) * | 2021-04-14 | 2024-02-02 | 华熙生物科技股份有限公司 | 一种复合益生元及其在调节肠道功能中的应用 |
GR20220100433A (el) * | 2022-05-24 | 2023-12-11 | Θεοδοσιος Ιωαννη Λαζαρελης | Φυσικο προϊον για την υγεια της περι-πρωκτικης περιοχης |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19540749A1 (de) | 1995-11-02 | 1997-05-07 | Beiersdorf Ag | Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden |
US6242010B1 (en) * | 1999-07-21 | 2001-06-05 | Thione International, Inc. | Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions |
DE10006578C2 (de) | 2000-02-14 | 2002-10-31 | Bitop Ag | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
ITMI20020404A1 (it) * | 2002-02-28 | 2003-08-28 | Ist Naz Stud Cura Dei Tumori | Nuova manganese superossido dismutasi umana |
DE10317400B4 (de) | 2003-04-15 | 2006-04-13 | Universitätsklinikum Hamburg-Eppendorf | EX-VIVO-Hautorganmodell aus Schweinehaut |
JP2004331579A (ja) * | 2003-05-08 | 2004-11-25 | Noevir Co Ltd | 真皮マトリックス産生促進剤 |
DE10330243A1 (de) | 2003-07-03 | 2005-01-20 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis |
AT504347B8 (de) * | 2006-09-21 | 2008-09-15 | Univ Graz Tech | Verfahren zur herstellung von glucosederivaten |
CA2665984C (en) * | 2006-10-12 | 2017-02-28 | Activbiotics, Inc. | Superoxide dismutase mimetics for the treatment of oral mucositis |
DE102006056766A1 (de) | 2006-12-01 | 2008-06-05 | Bitop Ag | Verwendung von kompatiblen Soluten |
DE102007052380A1 (de) * | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
DE102008039231A1 (de) * | 2008-08-22 | 2010-02-25 | Bitop Ag | Verwendung von Glucosylglycerol |
DE102008053549A1 (de) * | 2008-10-28 | 2010-04-29 | Bitop Ag | Glucosylglycerol enthaltende Zusammensetzung |
JP2009161564A (ja) * | 2009-04-23 | 2009-07-23 | Tokiwa Yakuhin Kogyo Kk | アトピー性皮膚炎治療用組成物 |
EP2570124B1 (en) * | 2010-05-14 | 2016-11-02 | Sanidad Y Residencias 21, S.A. | Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics |
CN102247374B (zh) * | 2011-04-22 | 2013-05-22 | 山东弘立医学动物实验研究有限公司 | 含有四氢嘧啶及其衍生物的治疗皮肤创伤的药物 |
CN102357097A (zh) * | 2011-09-01 | 2012-02-22 | 朱道辰 | 一种预防和治疗皮肤冻伤的药物 |
-
2012
- 2012-07-09 DE DE102012013482.7A patent/DE102012013482A1/de not_active Withdrawn
-
2013
- 2013-06-19 WO PCT/EP2013/062708 patent/WO2014009118A1/de active Application Filing
- 2013-06-19 PL PL13737554T patent/PL2869854T3/pl unknown
- 2013-06-19 TR TR2019/09626T patent/TR201909626T4/tr unknown
- 2013-06-19 PT PT13737554T patent/PT2869854T/pt unknown
- 2013-06-19 HU HUE13737554 patent/HUE044118T2/hu unknown
- 2013-06-19 EP EP13737554.9A patent/EP2869854B1/de active Active
- 2013-06-19 ES ES13737554T patent/ES2734252T3/es active Active
- 2013-06-19 EP EP16196808.6A patent/EP3153185B1/de active Active
- 2013-06-19 US US14/413,061 patent/US20150297592A1/en not_active Abandoned
- 2013-06-19 CN CN201710365047.1A patent/CN107252427B/zh active Active
- 2013-06-19 DK DK13737554.9T patent/DK2869854T3/da active
- 2013-06-19 CN CN201380041224.0A patent/CN104540532A/zh active Pending
- 2013-06-19 EP EP19165150.4A patent/EP3536351A1/de not_active Withdrawn
- 2013-06-19 ES ES16196808T patent/ES2800915T3/es active Active
-
2017
- 2017-03-24 US US15/469,055 patent/US20170189435A1/en not_active Abandoned
-
2021
- 2021-03-31 US US17/218,814 patent/US20210213039A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE102012013482A1 (de) | 2014-01-09 |
EP3153185B1 (de) | 2020-03-25 |
ES2734252T3 (es) | 2019-12-05 |
CN107252427B (zh) | 2021-11-26 |
TR201909626T4 (tr) | 2019-07-22 |
EP3153185A1 (de) | 2017-04-12 |
EP2869854A1 (de) | 2015-05-13 |
WO2014009118A1 (de) | 2014-01-16 |
US20150297592A1 (en) | 2015-10-22 |
ES2800915T3 (es) | 2021-01-05 |
EP3536351A1 (de) | 2019-09-11 |
CN104540532A (zh) | 2015-04-22 |
EP2869854B1 (de) | 2019-04-10 |
HUE044118T2 (hu) | 2019-10-28 |
US20170189435A1 (en) | 2017-07-06 |
DK2869854T3 (da) | 2019-07-22 |
PL2869854T3 (pl) | 2019-09-30 |
US20210213039A1 (en) | 2021-07-15 |
CN107252427A (zh) | 2017-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2869854T (pt) | Composição contendo ectoína ou hidroxiectoína como substância ativa, para promover a regeneração de tecido corporal lesionado | |
GB2511713B (en) | Compositions for the treatment of bone fragility | |
AP2014007533A0 (en) | Substituted benzylindazoles for use as BUB1 kinaseinhibitors in the treatment of hyperproliferative diseases | |
EP2654745A4 (en) | COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN | |
PL2618768T3 (pl) | Układ laserowy do traktowania tkanek ciała | |
HK1184370A1 (zh) | 用於治療疼痛的藥物組合 | |
HK1202458A1 (en) | Glucokinase activator compositions for the treatment of diabetes | |
IL237568A0 (en) | Assembly for the treatment of biological tissues | |
HK1182015A1 (zh) | 活性藥物化合物用於治療中樞神經系統病症的用途 | |
HRP20181761T1 (hr) | Novi pripravak alfentanila za liječenje akutne boli | |
HK1215794A1 (zh) | 用於治療疾病的同種異體自噬體富集組合物 | |
HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
HK1210421A1 (en) | Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3- | |
PT2456445E (pt) | Agente para o tratamento de condições da pele | |
HUP1200552A2 (en) | Pharmaceutical compositions for the treatment of high blood pressure | |
GB201010638D0 (en) | Composition for treatment of skin | |
HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
GB201016834D0 (en) | Composition for skin treatment | |
GB201016836D0 (en) | Composition for skin treatment |